The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...